Login
← Go Back
Indegene
INDGN · Pharma > Pharmaceuticals & Drugs Listing date: May 13, 2024
Stock Price vs Company Growth
1d
0.8%
1w
3.0%
1m
0.6%
3m
12.3%
6m
20.0%
all
12.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 640 0.8%
555
737
Company Overview
Sales
2,672 Cr
Growth: 4.3%
Profit after Tax
347 Cr
Growth: 7.2%
Mid Cap
15,322 Cr
P/E: 42.2x
Industry P/E: 35.6x
Fundamentals
Sales (Cr) ₹ 2,672
Growth 4.3%
EBITDA 19.3%
P/S 5.7x
Dividend 0.0%
P/E 42.2x
Book Value ₹ 67.4
PEG Ratio 9.8x
ROE 24.0%
P/B 9.5x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company’s Enterprise Commercial Solutions primarily involve assisting life sciences companies with their digital marketing operations. Service providers in this segment assist life sciences companies by creating customized marketing plans and campaigns, expanding their reach to healthcare professionals (HCPs), and providing insights on HCP preferences.
Belongs to (10 Indices) view more